Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  White, Steven R ^a   Floreth, Timothy ^a   Liao, Chuanhong ^a   Bhorade, Sangeeta M ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; BIOLOGICAL MARKER;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; LONG TERM SURVIVAL; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; REGULATORY T LYMPHOCYTE; RETROSPECTIVE STUDY; T LYMPHOCYTE; ACUTE DISEASE; ADVERSE EFFECTS; AGED; BLOOD; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; IMMUNOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; SOLUBILITY; TIME;

ACUTE DISEASE; AGED; BIOMARKERS; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GRAFT REJECTION; HLA-G ANTIGENS; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SOLUBILITY; TIME FACTORS;

EID: 84904881508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103643     Document Type: Article

References (29)

1. Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, et al. (2008) Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant 27: 957-969.
2. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, et al. (1995) Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 110: 4-13; discussion 13-14.
3. Todd JL, Palmer SM (2011) Bronchiolitis obliterans syndrome: the final frontier for lung transplantation. Chest 140: 502-508.
4. Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, et al. (2005) Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 76: 349-357. (Pubitemid 40129561)
5. Ishitani A, Geraghty DE (1992) Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 89: 3947-3951.
6. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, et al. (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186: 1809-1818. (Pubitemid 27524591)
7. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, et al. (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160: 3096-3100. (Pubitemid 28164696)
8. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, et al. (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25high-FOXP3+ regulatory T cells. Stem Cells 26: 212-222.
9. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, et al. (2001) HLA-G2, - G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166: 5018-5026. (Pubitemid 32280714)
10. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED (2001) Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the alloproliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci U S A 98: 12150-12155. (Pubitemid 32959842)
11. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, et al. (2003) Soluble HLA-A,- B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33: 125-134. (Pubitemid 36157650)
12. LeMaoult J, Krawice-Radanne I, Dausset J, Carosella ED (2004) HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells. Proc Natl Acad Sci U S A 101: 7064-7069. (Pubitemid 38596443)
13. Le Rond S, Azema C, Krawice-Radanne I, Durrbach A, Guettier C, et al. (2006) Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/regulatory T cells. J Immunol 176: 3266-3276.
14. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, et al. (2002) Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105: 1949-1954. (Pubitemid 34437623)
15. Luque J, Torres MI, Aumente MD, Marin J, Garcia-Jurado G, et al. (2006) Soluble HLA-G in heart transplantation: their relationship to rejection episodes and immunosuppressive therapy. Hum Immunol 67: 257-263. (Pubitemid 44255786)
16. Basturk B, Karakayali F, Emiroglu R, Sozer O, Haberal A, et al. (2006) Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation. Transplant Proc 38: 571-574.
17. Qiu J, Terasaki PI, Miller J, Mizutani K, Cai J, et al. (2006) Soluble HLA-G expression and renal graft acceptance. Am J Transplant 6: 2152-2156. (Pubitemid 44199549)
18. Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, et al. (2007) CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance. Blood 110: 3936-3948. (Pubitemid 350248449)
19. Brugiere O, Thabut G, Pretolani M, Krawice-Radanne I, Dill C, et al. (2009) Immunohistochemical study of HLA-G expression in lung transplant recipients. Am J Transplant 9: 1427-1438.
20. Bhorade SM, Chen H, Molinero L, Liao C, Garrity ER, et al. (2010) Decreased percentage of CD4 +FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 90: 540-546.
21. Rezvani K, Mielke S, Ahmadzadeh M, Kilical Y, Savani BN, et al. (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108: 1291-1297. (Pubitemid 44232027)
22. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, et al. (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26: 1229-1242. (Pubitemid 350256994)
23. Holtzman MJ, Patel DA, Zhang Y, Patel AC (2011) Host epithelial-viral interactions as cause and cure for asthma. Curr Opin Immunol 23: 487-494.
24. Pangault C, Le Friec G, Caulet-Maugendre S, Lena H, Amiot L, et al. (2002) Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Hum Immunol 63: 83-90. (Pubitemid 34132584)
25. Hicheri Y, Bouchekioua A, Hamel Y, Henry A, Rouard H, et al. (2008) Donor regulatory T cells identified by FoxP3 expression but also by the membranous CD4+CD127low/neg phenotype influence graft-versus-tumor effect after donor lymphocyte infusion. J Immunother 31: 806-811.
26. Noel G, Bruniquel D, Birebent B, DeGuibert S, Grosset JM, et al. (2008) Patients suffering from acute graft-versus-host disease after bone-marrow transplantation have functional CD4+CD25hiFoxp3+ regulatory T cells. Clin Immunol 129: 241-248.
27. Pirri A, Contieri FC, Benvenutti R, Bicalho Mda G (2009) A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. Transpl Immunol 20: 143-149.
28. Piancatelli D, Maccarone D, Liberatore G, Parzanese I, Clemente K, et al. (2009) HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with metabolic complications. Transplant Proc 41: 1187-1188.
29. La Nasa G, Littera R, Locatelli F, Lai S, Alba F, et al. (2007) The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated bone marrow transplantation for thalassaemia. Br J Haematol 139: 284-288. (Pubitemid 47493086)